Glenn M Eastwood1, Aiko Tanaka2, Emilo Daniel Valenzuela Espinoza3, Leah Peck4, Helen Young5, Johan Mårtensson6, Ling Zhang7, Neil J Glassford8, Yu-Feng Frank Hsiao9, Satoshi Suzuki10, Rinaldo Bellomo11. 1. Department of Intensive Care, Austin Hospital, Melbourne, Australia; School of Nursing and Midwifery, Faculty of Health, Deakin University, Melbourne, Australia; ANZIC-RC, Monash University, Victoria, Australia. Electronic address: glenn.eastwood@austin.org.au. 2. Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Anesthesiology and Intensive Care, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: aiko.tanaka@austin.org.au. 3. Department of Intensive Care, Austin Hospital, Melbourne, Australia. Electronic address: edve84@gmail.com. 4. Department of Intensive Care, Austin Hospital, Melbourne, Australia. Electronic address: leah.peck@austin.org.au. 5. Department of Intensive Care, Austin Hospital, Melbourne, Australia. Electronic address: helen.young@austin.org.au. 6. Department of Intensive Care, Austin Hospital, Melbourne, Australia; ANZIC-RC, Monash University, Victoria, Australia; Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. Electronic address: johan.martensson@austin.org.au. 7. Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Nephrology, West China Medical School, West China Hospital, China. Electronic address: zhanglinglzy@163.com. 8. Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Anesthesiology and Intensive Care, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: neil.glassford@austin.org.au. 9. Department of Intensive Care, Austin Hospital, Melbourne, Australia. Electronic address: frank.yfh@gmail.com. 10. Department of Nephrology, West China Medical School, West China Hospital, China. Electronic address: Suzuki-s@mtc.biglobe.ne.jp. 11. Department of Intensive Care, Austin Hospital, Melbourne, Australia; ANZIC-RC, Monash University, Victoria, Australia. Electronic address: rinaldo.bellomo@austin.org.au.
Abstract
BACKGROUND: In mechanically ventilated (MV) cardiac arrest (CA) survivors admitted to the intensive care unit (ICU) avoidance of hypoxia is considered crucial. However, avoidance of hyperoxia may also be important. A conservative approach to oxygen therapy may reduce exposure to both. METHODS: We evaluated the introduction of conservative oxygen therapy (target SpO2 88-92% using the lowest FiO2) during MV for resuscitated CA patients admitted to the ICU. RESULTS: We studied 912 arterial blood gas (ABG) datasets: 448 ABGs from 50 'conventional' and 464 ABGs from 50 'conservative' oxygen therapy patients. Compared to the conventional group, conservative group patients had significantly lower PaO2 values and FiO2 exposure (p<0.001, respectively); more received MV in a spontaneous ventilation mode (18% vs 2%; p=0.001) and more were exposed to a FiO2 of 0.21 (19 vs 0 patients, p=0.001). Additionally, according to mean PaO2, more conservative group patients were classified as normoxaemic (36 vs 16 patients, p<0.01) and fewer as hyperoxaemic (14 vs 33 patients, p<0.01). Finally, ICU length of stay was significantly shorter for conservative group patients (p=0.04). There was no difference in the proportion of survivors discharged from hospital with good neurological outcome (14/23 vs 12/22 patients, p=0.67). CONCLUSIONS: Our findings provide preliminary support for the feasibility and physiological safety of conservative oxygen therapy in patients admitted to ICU for MV support after cardiac arrest (Trial registration, NCT01684124).
BACKGROUND: In mechanically ventilated (MV) cardiac arrest (CA) survivors admitted to the intensive care unit (ICU) avoidance of hypoxia is considered crucial. However, avoidance of hyperoxia may also be important. A conservative approach to oxygen therapy may reduce exposure to both. METHODS: We evaluated the introduction of conservative oxygen therapy (target SpO2 88-92% using the lowest FiO2) during MV for resuscitated CA patients admitted to the ICU. RESULTS: We studied 912 arterial blood gas (ABG) datasets: 448 ABGs from 50 'conventional' and 464 ABGs from 50 'conservative' oxygen therapy patients. Compared to the conventional group, conservative group patients had significantly lower PaO2 values and FiO2 exposure (p<0.001, respectively); more received MV in a spontaneous ventilation mode (18% vs 2%; p=0.001) and more were exposed to a FiO2 of 0.21 (19 vs 0 patients, p=0.001). Additionally, according to mean PaO2, more conservative group patients were classified as normoxaemic (36 vs 16 patients, p<0.01) and fewer as hyperoxaemic (14 vs 33 patients, p<0.01). Finally, ICU length of stay was significantly shorter for conservative group patients (p=0.04). There was no difference in the proportion of survivors discharged from hospital with good neurological outcome (14/23 vs 12/22 patients, p=0.67). CONCLUSIONS: Our findings provide preliminary support for the feasibility and physiological safety of conservative oxygen therapy in patients admitted to ICU for MV support after cardiac arrest (Trial registration, NCT01684124).
Authors: Brian W Roberts; J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Pierce; Michael Donnino; Marion Leary; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak Journal: Circulation Date: 2018-02-01 Impact factor: 29.690
Authors: Chiara Robba; Rafael Badenes; Florian Ebner; Paolo Pelosi; Denise Battaglini; Lorenzo Ball; Filippo Sanfilippo; Iole Brunetti; Janus Christian Jakobsen; Gisela Lilja; Hans Friberg; Pedro David Wendel-Garcia; Paul J Young; Glenn Eastwood; Michelle S Chew; Johan Unden; Matthew Thomas; Michael Joannidis; Alistair Nichol; Andreas Lundin; Jacob Hollenberg; Naomi Hammond; Manoj Saxena; Annborn Martin; Miroslav Solar; Fabio Silvio Taccone; Josef Dankiewicz; Niklas Nielsen; Anders Morten Grejs Journal: Crit Care Date: 2022-10-21 Impact factor: 19.334
Authors: R Stolmeijer; H R Bouma; J G Zijlstra; A M Drost-de Klerck; J C Ter Maaten; J J M Ligtenberg Journal: Biomed Res Int Date: 2018-05-14 Impact factor: 3.411
Authors: Edward Palmer; Benjamin Post; Roman Klapaukh; Giampiero Marra; Niall S MacCallum; David Brealey; Ari Ercole; Andrew Jones; Simon Ashworth; Peter Watkinson; Richard Beale; Stephen J Brett; J Duncan Young; Claire Black; Aasiyah Rashan; Daniel Martin; Mervyn Singer; Steve Harris Journal: Am J Respir Crit Care Med Date: 2019-12-01 Impact factor: 21.405
Authors: Jasmeet Soar; Katherine M Berg; Lars W Andersen; Bernd W Böttiger; Sofia Cacciola; Clifton W Callaway; Keith Couper; Tobias Cronberg; Sonia D'Arrigo; Charles D Deakin; Michael W Donnino; Ian R Drennan; Asger Granfeldt; Cornelia W E Hoedemaekers; Mathias J Holmberg; Cindy H Hsu; Marlijn Kamps; Szymon Musiol; Kevin J Nation; Robert W Neumar; Tonia Nicholson; Brian J O'Neil; Quentin Otto; Edison Ferreira de Paiva; Michael J A Parr; Joshua C Reynolds; Claudio Sandroni; Barnaby R Scholefield; Markus B Skrifvars; Tzong-Luen Wang; Wolfgang A Wetsch; Joyce Yeung; Peter T Morley; Laurie J Morrison; Michelle Welsford; Mary Fran Hazinski; Jerry P Nolan Journal: Resuscitation Date: 2020-10-21 Impact factor: 5.262